Q&As in 2023

Filter By:

Article Type
Year
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Bill Martin, Global Therapeutic Area Head, Neuroscience at Johnson & Johnson Innovative Medicine. We discussed the challenges and opportunities ahead for the development of treatments for psychiatric disease.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved, and where it is heading. This month, we are talking to Ukpong Eyo (Associate Professor of Neuroscience at the University of Virginia, USA), a glial biologist interested in the role of microglia in neurodevelopment, health and disease, about science, family, and the benefits of finding your balance.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Kelsey Martin, Executive Vice President of Autism and Neuroscience at the Simons Foundation and Professor in the Department of Biological Chemistry at the University of California, Los Angeles (UCLA), where she previously served as the Dean of the David Geffen School of Medicine. We discussed the pleasures of studying neuronal cell biology and her leadership roles.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved, and where it is heading. This month, we are talking to Corey Harwell, Associate Professor of Neurology at the University of California, San Francisco (UCSF) School of Medicine. We spoke about the mentors who shaped his early interest in neuroscience, and how his lab lets their data lead them in interesting directions.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month, we are talking to Costantino Iadecola (Director and Chair of the Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, NY, USA), a neurovascular biologist and physician interested in the roles of vasculature, hypertension and immune cells in ischemic stroke and neurodegenerative diseases.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved and where it is heading. This month, we are talking to Theanne Griffith, Assistant Professor in the Department of Physiology and Membrane Biology at the University of California, Davis. We spoke about how she discovered her passion for biophysics and her work as an author of children’s books about science.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Freda Miller, Deputy Director and Professor of Developmental Neurobiology at University of British Columbia. She is known for her work on neuronal and mesenchymal stem and precursor cells and how they can promote tissue repair and regeneration. Here we talk about science and how to make your mark.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved, and where it is heading. This month, we are talking to Marguerite Matthews, Program Director at the Office of Programs to Enhance Neuroscience Workforce Diversity at the National Institute of Neurological Disorders and Stroke (NINDS) in the US. We spoke about how she transitioned from neuroscience research into a public service career, her work to promote diversity, equity and inclusion, and how each of us can champion these causes in our communities.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Richard Tsien, the Druckenmiller Professor of Neuroscience in the Department of Neuroscience and Physiology at New York University Langone Medical Center. We discussed his upbringing and wide-ranging career, which has included foundational research on Ca2+ channels and synaptic plasticity.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved, and where it is heading. This month, we are talking to Andrew Huberman, Associate Professor of Neurobiology at Stanford University and host of the very popular Huberman Lab podcast. We spoke about his path into science communication, his work on the podcast, and how he handles his newfound fame.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved and where it is heading. This month, we are talking to Mario Penzo, Chief of the Section on the Neural Circuits of Emotion and Motivation at the US National Institute of Mental Health (NIMH). We spoke about his early life in the Dominican Republic and his work on neural circuits underlying behavior.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Rusty Gage, who is the Vi and John Adler chair for Research on Age-Related Neurodegenerative Disease and Professor of Genetics at The Salk Institute. He is known for his work on neurogenesis in the adult brain and on modelling diseases using human stem cells.

    • Rebecca Wright
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Carla Shatz, who is the Sapp Family Provostial Professor, Catherine Holman Johnson Director of Stanford Bio-X, and Professor of Biology and Neurobiology at Stanford University. Her work has illuminated mechanisms of visual system development and plasticity and has focused more recently on synaptic pruning mechanisms.

    • Shari Wiseman
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Klaus-Armin Nave (Director at the Max Planck Institute for Multidisciplinary Sciences, Germany), a glia researcher and molecular biologist who is interested in glia–neuron interactions and a pioneer in the study of the ability of myelinating cells to metabolically support axons.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved and where it is heading. This month, we are talking to Lucina Q. Uddin, professor-in-residence at Psychiatry and Biobehavioral Sciences at the University of California Los Angeles and the 2022–2023 Chair of the Diversity & Inclusivity Committee for the Organization for Human Brain Mapping. She uses neuroimaging to study brain networks that support behavior in typically developing children and children with autism. She spoke with me about how she became interested in neuroscience, her career trajectory, and personal experiences that led to her efforts in promoting diversity, equity and inclusion.

    • Jean Mary Zarate
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Michal Schwartz at the Weizmann Institute of Science, Israel, a neuroimmunologist and pioneer in the study of the role of the immune system in physiology and in diseases of the central nervous system. She is the winner of the 2023 Israel Prize in Life Sciences.

    • Elisa Floriddia
    Q&A
  • As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how neuroscience has evolved, and where it is heading. This month, we are talking to Nii Addy, the Albert E. Kent Associate Professor of Psychiatry and Associate Professor of Cellular and Molecular Physiology, and the inaugural Director of Scientist Diversity and Inclusion at Yale School of Medicine. Dr Addy studies dopamine, motivation, and addiction, and spoke with me about promoting diversity, how to be a good mentor, and communicating with the public via his popular podcast.

    • Shari Wiseman
    Q&A
  • To mark the 25th anniversary of Nature Neuroscience, Shari Wiseman spoke with each of the past Chief Editors of the journal: Charles Jennings (1998–2003), Sandra Aamodt (2003–2008), Kalyani Narasimhan (2008–2014), Meredith LeMasurier (2014–2016), and Kevin Da Silva (2016–2021). They shared their memories and insights about the journal’s early days, scientific publishing, and the field of neuroscience.

    • Shari Wiseman
    Q&A